PubMed HealthSearch

PubMed · 6998330

Thrombophlebitis: diagnostic techniques.

Abstract

A review of the extensive literature on the diagnosis of deep vein thrombophlebitis (DVT) is presented. DVT affects approximately 10% of all patients with superficial thrombophlebitis. Many authors have shown that the clinical finding of DVT are unreliable. Although pulmonary emboli are relatively frequent in all patients with calf DVT, these emboli are generally not associated with clincial events. Venography is the "gold standard" of diagnostic tests, but it is too cumbersome to be practical as a screening procedure. Radioisotope-labeled fibrinogen is reasonable accurate in diagnosing calf DVT, but much less so in proximal lesions. The results of Doppler ultrasound and impedance plethysmography (IPG) agree with those of venography in 90% of the cases of proximal DVT.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

T D Painter. 1980. Thrombophlebitis: diagnostic techniques.. https://doi.org/10.1177/000331978003100603

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Novel thiazole-based heterocycles as selective inhibitors of fibrinogen-mediated platelet aggregation.

The synthesis and biological activity of novel thiazole-based heterocycles as inhibitors of thrombin-induced human platelet aggregation are described. Further evaluation of selected compounds show they inhibit platelet aggregation as stimulated by a variety of agonists. The more active compounds also were found to inhibit fibrinogen binding to platelets. To further delineate the mechanism of action of these compounds, direct binding studies with the purified glycoprotein (GP) IIb/IIIa receptor were performed. Flow cytometry analyses of 24 and 32 indicate that these compounds block the activation process of the GPIIb/IIIa receptor without denaturing the integrin receptor. On the basis of these studies, 32 exhibited the best profile as a novel nonpeptide inhibitor of fibrinogen-mediated platelet aggregation.

Fibrinogen